Comparative Treatment Study on Macular Edema Secondary to Branch Retinal Vein Occlusion by Intravitreal Ranibizumab with and without Selective Retina Therapy

被引:4
作者
Yamamoto, Manabu [1 ]
Miura, Yoko [2 ,3 ,4 ]
Hirayama, Kumiko [1 ]
Kyo, Akika [1 ]
Kohno, Takeya [1 ]
Theisen-Kunde, Dirk [4 ]
Brinkmann, Ralf [2 ,4 ]
Honda, Shigeru [1 ]
机构
[1] Osaka Metropolitan Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Osaka 5458585, Japan
[2] Univ Lubeck, Inst Biomed Opt, D-23562 Lubeck, Germany
[3] Univ Lubeck, Dept Ophthalmol, D-23562 Lubeck, Germany
[4] Med Laser Ctr Lubeck, D-23562 Lubeck, Germany
来源
LIFE-BASEL | 2023年 / 13卷 / 03期
关键词
retinal laser therapy; branch retinal vein occlusion; macular edema; selective retina therapy; anti-VEGF therapy; ranibizumab; SUSTAINED BENEFITS; LASER TREATMENT; SRT; PHOTOCOAGULATION; AFLIBERCEPT;
D O I
10.3390/life13030769
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of this study was to compare the safety and efficacy of selective retina therapy (SRT) combined with the intravitreal injection of ranibizumab (IVR) in patients with macular edema (ME) secondary to branch retinal vein occlusion (BRVO). This trial was a 12-month single-center, randomized, single-masked prospective study. Eligible patients were randomized (1:1) to IVR and SRT (IVR + SRT group), or IVR and sham SRT (IVR + sham group). After the initial IVR, all participants received ME resolution criteria-driven pro re nata treatment. SRT or sham SRT was always applied one day after IVR. The primary outcome measure of this study was the mean change in central macular thickness (CMT) from baseline, and the secondary outcome measures were the mean change in visual acuity from baseline and the number of IVR treatments at a 52-week follow-up. Thirteen patients were in the IVR + SRT group, and 11 were in the IVR + sham group. Compared to the baseline, mean CMT and BCVA improved significantly after 52 weeks in both groups, with no significant difference between the two groups. The mean number of IVR was 2.85 +/- 1.52 in the IVR + SRT group and 4.73 +/- 2.33 in the IVR + sham group at the 52-week follow-up, with a significant difference between the two groups (p < 0.05). IVR combined with SRT may significantly decrease the number of IVR treatments while maintaining the visual and anatomical improvement effect of IVR monotherapy.
引用
收藏
页数:12
相关论文
共 40 条
[31]  
Richert Elisabeth, 2020, Cytokine X, V2, P100031, DOI 10.1016/j.cytox.2020.100031
[32]  
Roider J, 1999, ARCH OPHTHALMOL-CHIC, V117, P1028
[33]   Selective retina therapy (SRT) for clinically significant diabetic macular edema [J].
Roider, Johann ;
Liew, Shiao Hui Melissa ;
Klatt, Carsten ;
Elsner, Hanno ;
Poerksen, Erk ;
Hillenkamp, Jost ;
Brinkmann, Ralf ;
Birngruber, Reginald .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (09) :1263-1272
[34]   RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen [J].
Schuele, G ;
Rumohr, M ;
Huettmann, G ;
Brinkmann, R .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (02) :714-719
[35]   Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial [J].
Song, Shuang ;
Yu, Xiaobing ;
Zhang, Peng ;
Gu, Xiaoya ;
Dai, Hong .
BMC OPHTHALMOLOGY, 2020, 20 (01)
[36]   Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion [J].
Tadayoni, Ramin ;
Waldstein, Sebastian M. ;
Boscia, Francesco ;
Gerding, Heinrich ;
Gekkieva, Margarita ;
Barnes, Elizabeth ;
Das Gupta, Ayan ;
Wenzel, Andreas ;
Pearce, Ian .
OPHTHALMOLOGY, 2017, 124 (12) :1778-1787
[37]   COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION 6-MONTH RESULT [J].
Terashima, Hiroko ;
Hasebe, Hiruma ;
Okamoto, Fumiki ;
Matsuoka, Naoki ;
Sato, Yayoi ;
Fukuchi, Takeo .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (07) :1377-1384
[38]  
Yamamoto Manabu, 2020, Am J Ophthalmol Case Rep, V19, P100794, DOI 10.1016/j.ajoc.2020.100794
[39]   Predictive factors of outcome of selective retina therapy for diabetic macular edema [J].
Yamamoto, Manabu ;
Miura, Yoko ;
Hirayama, Kumiko ;
Kohno, Takeya ;
Kabata, Daijiro ;
Theisen-Kunde, Dirk ;
Brinkmann, Ralf ;
Honda, Shigeru .
INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (05) :1221-1232
[40]   Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy [J].
Yasui, Ayako ;
Yamamoto, Manabu ;
Hirayama, Kumiko ;
Shiraki, Kunihiko ;
Theisen-Kunde, Dirk ;
Brinkmann, Ralf ;
Miura, Yoko ;
Kohno, Takeya .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (02) :243-254